Featured Posts
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Search Posts
Newsletter
Economic Projections, Comcast Sues the FCC and Cholesterol Drugs
A new report from the Federal Reserve projects continued slow growth and a weak business climate. Comcast sues the Federal Communications Commission over…
Newsletter
Stem Cells, Mad Cow Disease and Cuba’s Police
Scientists hail a new breakthrough in stem cell research. A federal Appeals Court rules that the U.S. Department of Agriculture can forbid private meat packers…
Op-Eds
Cholesterol Drug Scare Shenanigans
Why is the editor of the New England Journal of Medicine encouraging a cancer scare over the cholesterol-lowering drug Vytorin? Is he overcompensating for past…
News Release
Public Funding for Stem Cell Research: Boon or Boondoggle?
Debates over the ethics of research using human embryonic stem cells continue long after the Bush Administration’s ban on federal tax-funding for such research. But,…
Study
Public Stem Cell Research Funding
The best way to make progress in stem cell research is to allow the private sector to grow, unimpeded by regulation and controversy.
Newsletter
Fannie Mae, HIV Rates and Greenhouse Gases
Mortgage giant Fannie Mae announces a shakeup of its senior management. A new study finds New York City’s HIV infection rate to be three times…